1-5 of 5
Cyrus Hedvat
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome

Su-Jiang Zhang, Raajit Rampal, Taghi Manshouri, Jay Patel, Nana Mensah, Andrew Kayserian, Todd Hricik, Adriana Heguy, Cyrus Hedvat, Mithat Gönen, Hagop Kantarjian, Ross L. Levine, Omar Abdel-Wahab, Srdan Verstovsek
Journal: Blood
Blood (2012) 119 (19): 4480–4485.
https://doi.org/10.1182/blood-2011-11-390252
Published: 2012
Includes: Supplemental data
Journal Articles

Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV + lymphomas after allogeneic hematopoietic cell transplantation

Clinical Trials & Observations
Ekaterina Doubrovina, Banu Oflaz-Sozmen, Susan E. Prockop, Nancy A. Kernan, Sara Abramson, Julie Teruya-Feldstein, Cyrus Hedvat, Joanne F. Chou, Glenn Heller, Juliet N. Barker, Farid Boulad, Hugo Castro-Malaspina, Diane George, Ann Jakubowski, Guenther Koehne, Esperanza B. Papadopoulos, Andromachi Scaradavou, Trudy N. Small, Ramzi Khalaf, James W. Young, Richard J. O'Reilly
Journal: Blood
Blood (2012) 119 (11): 2644–2656.
https://doi.org/10.1182/blood-2011-08-371971
Published: 2012
Includes: Supplemental data
Journal Articles

Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosis

Priya Koppikar, Omar Abdel-Wahab, Cyrus Hedvat, Sachie Marubayashi, Jay Patel, Aviva Goel, Nicole Kucine, Jeffrey R. Gardner, Andrew P. Combs, Kris Vaddi, Patrick J. Haley, Timothy C. Burn, Mark Rupar, Jacqueline F. Bromberg, Mark L. Heaney, Elisa de Stanchina, Jordan S. Fridman, Ross L. Levine
Journal: Blood
Blood (2010) 115 (14): 2919–2927.
https://doi.org/10.1182/blood-2009-04-218842
Published: 2010
Includes: Supplemental data
Journal Articles

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies

Brief Report
Omar Abdel-Wahab, Ann Mullally, Cyrus Hedvat, Guillermo Garcia-Manero, Jay Patel, Martha Wadleigh, Sebastien Malinge, JinJuan Yao, Outi Kilpivaara, Rukhmi Bhat, Kety Huberman, Sabrena Thomas, Igor Dolgalev, Adriana Heguy, Elisabeth Paietta, Michelle M. Le Beau, Miloslav Beran, Martin S. Tallman, Benjamin L. Ebert, Hagop M. Kantarjian, Richard M. Stone, D. Gary Gilliland, John D. Crispino, Ross L. Levine
Journal: Blood
Blood (2009) 114 (1): 144–147.
https://doi.org/10.1182/blood-2009-03-210039
Published: 2009
Includes: Supplemental data
Journal Articles

Risk-Adapted Intravenous Melphalan Followed by Adjuvant Dexamethasone (D) and Thalidomide (T) for Newly Diagnosed Patients with Systemic AL Amyloidosis (AL): Interim Results of a Phase II Study.

Adam D. Cohen, Ping Zhou, Lillian Reich, Alice Quinn, Sophia Fircanis, Lisa Drake, Cyrus Hedvat, Julie Teruya-Feldstein, Daniel A. Filippa, Martin Fleisher, Raymond L. Comenzo
Journal: Blood
Blood (2004) 104 (11): 542.
https://doi.org/10.1182/blood.V104.11.542.542
Published: 2004